Aspire Biopharma Warrant
ASBPW
29 hedge funds and large institutions have $251K invested in Aspire Biopharma Warrant in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
32.05% more ownership
Funds ownership: 0% → 32.05% (+32%)
0% more funds holding
Funds holding: 29 → 29 (0)
38% less capital invested
Capital invested by funds: $408K → $251K (-$157K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Antara Capital
New York
|
+$10.5K |
| 2 |
CS
Clear Street
New York
|
+$5.37K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.93K |
| 4 |
CA
Crossingbridge Advisors
Pleasantville,
New York
|
+$2.52K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$61 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCA
Taconic Capital Advisors
New York
|
-$13.4K |
| 2 |
AC
Athos Capital
Hong Kong
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BOCH
26
Blue Owl Capital Holdings
New York
| $1.5K | – | – | – |
|
|
PMAM
27
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
OAC
28
OMERS Administration Corp
Toronto,
Ontario, Canada
| $747 | – | – | – |
|
29
Osaic Holdings
Scottsdale,
Arizona
| $1 | – | – | – |
|
|
TCA
30
Taconic Capital Advisors
New York
| – | -$13.4K | -300,000 | Closed |
|
|
AC
31
Athos Capital
Hong Kong
| – | -$6K | -21,383 | Closed |
|
|
FTUS
32
Flow Traders U.S.
New York
| – | +$20 | +398 | +3% |
|
ASBPW Hedge Fund Activity: Q3 2025 in Review
29 of the 7,626 institutional investors tracked by Wall St. Rank reported a position in Aspire Biopharma Warrant (ASBPW) for Q3 2025, worth a combined $251K — down 38% from $408K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ASBPW positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Antara Capital, opening a new position worth an estimated $10.5K. The largest seller was Taconic Capital Advisors, exiting entirely with an estimated $13.4K sold.
- 29 institutional investors held Aspire Biopharma Warrant (ASBPW) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $251K of Aspire Biopharma Warrant stock for Q3 2025, down 38% quarter-over-quarter.
- 3 funds opened new Aspire Biopharma Warrant positions in Q3 2025 and 2 closed out, a net change of +1 holder.
- The largest Aspire Biopharma Warrant buyer in Q3 2025 was Antara Capital, an estimated $10.5K added.
- The largest Aspire Biopharma Warrant seller in Q3 2025 was Taconic Capital Advisors, an estimated $13.4K sold.
Based on aggregated 13F filings for Q3 2025.